SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-053436
Filing Date
2012-08-02
Accepted
2012-08-02 06:06:35
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13911_110q.htm 10-Q 829864
2 EX-10.2 a12-13911_1ex10d2.htm EX-10.2 63443
3 EX-31.1 a12-13911_1ex31d1.htm EX-31.1 10763
4 EX-31.2 a12-13911_1ex31d2.htm EX-31.2 11175
5 EX-32.1 a12-13911_1ex32d1.htm EX-32.1 8070
12 GRAPHIC g139111bei001.gif GRAPHIC 7890
  Complete submission text file 0001104659-12-053436.txt   5382730

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snta-20120630.xml EX-101.INS 701217
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20120630.xsd EX-101.SCH 39588
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20120630_cal.xml EX-101.CAL 50349
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20120630_lab.xml EX-101.LAB 652368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20120630_pre.xml EX-101.PRE 301702
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20120630_def.xml EX-101.DEF 216180
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 121001615
SIC: 2834 Pharmaceutical Preparations